Nanosphere to Present at the Jefferies 2013 Global Healthcare Conference

Nanosphere to Present at the Jefferies 2013 Global Healthcare Conference 
NORTHBROOK, IL -- (Marketwired) -- 06/03/13 --   Nanosphere, Inc.,
(NASDAQ: NSPH), a leader in the development and commercialization of
advanced molecular diagnostics systems, today announced that an
overview of the company's business and commercial strategy will be
given by Nanosphere's President and Chief Executive Officer Michael
McGarrity at the Jefferies 2013 Global Healthcare Conference, being
held at the Grand Hyatt Hotel in New York City. The Company
presentation is on Wednesday, June 5 at 2:00pm Eastern Time. 
A live webcast of Nanosphere's presentation will be available at
www.nanosphere.us. 
About Nanosphere, Inc.
 Nanosphere develops, manufactures and markets
an advanced molecular diagnostics platform, the Verigene(R) System,
for multiplexed infectious disease, genetic, and ultra-sensitive
protein testing. This easy-to-use platform offers laboratories a
convenient, simple, and cost-effective solution for highly sensitive
nucleic acid and protein testing. Nanosphere is based in Northbrook,
IL. 
For additional information regarding Nanosphere's infectious disease
products, please contact Nanosphere at IDtesting@nanosphere.us or
visit www.nanosphere.us. 
Except for historical information, the matters discussed in this
press release are "forward-looking statements" and are subject to
risks and uncertainties. Actual results could differ materially from
these forward-looking statements. Factors that could cause or
contribute to such differences include, but are not limited to, the
following: (i) Nanosphere's ability to develop commercially viable
products; (ii) Nanosphere's ability to achieve profitability; (iii)
Nanosphere's ability to produce and market its products; (iv)
Nanosphere's ability to obtain regulatory approval of its products;
(v) Nanosphere's ability to protect its intellectual property; (vi)
competition and alternative technologies; and (vii) Nanosphere's
ability to obtain additional financing to support its operations.
Additional risks are discussed in the Company's current filings with
the Securities and Exchange Commission. Although the Company believes
the expectations reflected in such forward-looking statements are
based on reasonable assumptions, it can give no assurance that its
expectations will be attained. The forward-looking statements are
made as of the date of this press release, and we undertake no
obligation to publicly update or revise any forward-looking
statement, whether as a result of new information, future events or
otherwise. 
Contact:
Nanosphere, Inc. 
Roger Moody
847-400-9021 
Chief Financial Officer 
rmoody@nanosphere.us  
LifeSci Advisors, LLC
Michael Rice
646-597-6979
Founding Partner
mrice@lifesciadvisors.com 
 
 
Press spacebar to pause and continue. Press esc to stop.